---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-047904"
form_type: "8-K"
ticker: "VYGR"
cik: "0001640266"
company_name: "Voyager Therapeutics, Inc."
filed_at: "2022-04-20T23:59:59+00:00"
generated_at: "2026-06-26T06:11:55.388638+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Two Voyager directors request not to be renominated; search for replacements underway

## Summary
- Mark Levin and Steven Paul, M.D. will not stand for re-election at 2022 annual meeting.
- Both directors cited desire to reduce professional commitments and board seats.
- Departures not due to any disagreement with board or management.
- Nominating committee has engaged search firm to fill anticipated vacancies.

## SEC filing metadata
- accession: 0001104659-22-047904
- form_type: 8-K
- ticker: VYGR
- cik: 0001640266
- company_name: Voyager Therapeutics, Inc.
- filed_at: 2022-04-20T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1640266/000110465922047904/0001104659-22-047904-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1640266/000110465922047904/tm2213132d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-047904
- JSON: https://secwatch.observer/filing/0001104659-22-047904.json
- Plain text: https://secwatch.observer/filing/0001104659-22-047904.txt

## Key facts
- Executive change
  Steven Paul, M.D. departed as Director at Voyager Therapeutics, Inc..
  - Action: requested not to be nominated
  - Role: Director
  source text: Mark Levin and Steven Paul, M.D. each requested not to be nominated for re-election to the Board when his current term expires at the Company’s 2022 annual meeting of stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1640266/000110465922047904/0001104659-22-047904-index.htm
- Executive change
  Mark Levin departed as Director at Voyager Therapeutics, Inc..
  - Action: requested not to be nominated
  - Role: Director
  source text: Mark Levin and Steven Paul, M.D. each requested not to be nominated for re-election to the Board when his current term expires at the Company’s 2022 annual meeting of stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1640266/000110465922047904/0001104659-22-047904-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.